Disclosures for "Study Design of Subcutaneous Efgartigimod PH20 in Juvenile Generalized Myasthenia Gravis"
-
Dr. Schwaede has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Schwaede has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen .
-
Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Affinia Therapeutics. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta.
-
Dr. Anna has received personal compensation for serving as an employee of argenx BV.
-
Dr. Menezes has received personal compensation for serving as an employee of argenx.
-
Dr. Giacobbe has received personal compensation for serving as an employee of argenx. Dr. Giacobbe has stock in argenx.
-
The institution of Mrs. van Bragt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Mrs. van Bragt has stock in argenx.
-
Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneka. Prof. Kostera-Pruszczyk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
-
Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pfizer. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Ramdas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.